LYMPHOID NEOPLASIA Reed-Sternberg cell – derived lymphotoxin- a activates endothelial cells to enhance T-cell recruitment in classical Hodgkin lymphoma

in involved lymph nodes from cHL patients. Our study also shows that although NF- k B and AP-1 are involved, the cyclooxygenase (COX) pathway is the dominant regulator of LT a production in HRS cells. Using pharmacologicalinhibitors,ourdatasuggestthatactivityofCOX1,butnotofCOX2,directlyregulatestheexpressionofnuclearc-Fos in HRS cells. Our findings suggest that HRS cell-derived LT a is an important mediator that contributes to T cell recruitment into lesional lymph nodes in cHL. ( Blood . 2014;124(19):2973-2982)

[1]  N. Nagelkerke,et al.  Epstein-Barr virus infection correlates with the expression of COX-2, p16(INK4A) and p53 in classic Hodgkin lymphoma. , 2013, International journal of clinical and experimental pathology.

[2]  C. Boeriu,et al.  Production methods for hyaluronan , 2013 .

[3]  Juan F. García,et al.  Expression of COX-2 on Reed-Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD. , 2012, Blood.

[4]  Michael R. Green,et al.  Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy , 2012, Clinical Cancer Research.

[5]  J. Lin,et al.  CD137 enhances monocyte-ICAM-1 interactions in an E-selectin-dependent manner under flow conditions. , 2010, Molecular immunology.

[6]  G. Nash,et al.  A role for the endothelial glycosaminoglycan hyaluronan in neutrophil recruitment by endothelial cells cultured for prolonged periods , 2009, Experimental cell research.

[7]  K. Karube,et al.  IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis. , 2008, Blood.

[8]  T. Randall,et al.  Development of secondary lymphoid organs. , 2008, Annual review of immunology.

[9]  M. Kramer,et al.  Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. , 2008, Cancer research.

[10]  Gloria Alvarez-Llamas,et al.  Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes. , 2007, Blood.

[11]  S. Monti,et al.  The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma , 2007, Proceedings of the National Academy of Sciences.

[12]  C. Heldin,et al.  Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB. , 2007, The Biochemical journal.

[13]  Dick W. Slaaf,et al.  The endothelial glycocalyx: composition, functions, and visualization , 2007, Pflügers Archiv - European Journal of Physiology.

[14]  Juan F. García,et al.  Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. , 2006, Blood.

[15]  Stephen R. Clark,et al.  Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere. , 2006, Blood.

[16]  P. Weigel,et al.  Recombinant human hyaluronan synthase 3 is phosphorylated in mammalian cells. , 2006, The Biochemical journal.

[17]  D. Baus,et al.  Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells , 2006, International journal of cancer.

[18]  M. Hino,et al.  Expression of cyclooxygenase-2 in Hodgkin's lymphoma:its role in cell proliferation and angiogenesis , 2006, Leukemia & lymphoma.

[19]  G. Mills,et al.  Inhibition of the phosphatidylinositol‐3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma , 2005, British journal of haematology.

[20]  R. Küppers,et al.  Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma. , 2005, Blood.

[21]  L. Young,et al.  Constitutive activation of phosphatidyl‐inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR , 2005, The Journal of pathology.

[22]  S. Kitano,et al.  Hyaluronic acid stimulates tumor-cell proliferation at wound sites. , 2004, Gastrointestinal endoscopy.

[23]  Ulrich H. von Andrian,et al.  Homing and cellular traffic in lymph nodes , 2003, Nature Reviews Immunology.

[24]  B. Aggarwal Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.

[25]  W. Lesslauer,et al.  Ectopic LTαβ Directs Lymphoid Organ Neogenesis with Concomitant Expression of Peripheral Node Addressin and a HEV-restricted Sulfotransferase , 2003, The Journal of experimental medicine.

[26]  L. Sánchez-Sánchez,et al.  NF-kappaB dependent activation of human endothelial cells treated with soluble products derived from human lymphomas. , 2003, Cancer letters.

[27]  H. Stein,et al.  Aberrantly expressed c‐Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF‐κB , 2002, The EMBO journal.

[28]  K. Ohshima,et al.  Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed‐Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells , 2002, International journal of cancer.

[29]  R. Gascoyne,et al.  Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. , 2002, Blood.

[30]  Hans Tesch,et al.  STAT3 is constitutively activated in Hodgkin cell lines. , 2001, Blood.

[31]  B. Dörken,et al.  Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. , 2001, Blood.

[32]  P. Roughley,et al.  Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. , 2001, The Biochemical journal.

[33]  S. Hanazawa,et al.  Prostaglandin E2 Stimulates AP-1-Mediated CD14 Expression in Mouse Macrophages Via Cyclic AMP-Dependent Protein Kinase A1 , 2000, The Journal of Immunology.

[34]  P. Heldin,et al.  Expression of human hyaluronan synthases in response to external stimuli. , 2000, The Biochemical journal.

[35]  H. Stein,et al.  Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. , 2000, Blood.

[36]  G. Fantuzzi,et al.  IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  P. DeAngelis Hyaluronan synthases: fascinating glycosyltransferases from vertebrates, bacterial pathogens, and algal viruses , 1999, Cellular and Molecular Life Sciences CMLS.

[38]  A. van den Berg,et al.  High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. , 1999, The American journal of pathology.

[39]  A. Tominaga,et al.  Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. , 1999, Journal of immunology.

[40]  G S Kansas,et al.  Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-alpha-activated endothelium under flow in vitro. , 1998, Journal of immunology.

[41]  G. Salles,et al.  Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients. , 1998, British Journal of Cancer.

[42]  I. Stamenkovic,et al.  Glycosylation Provides Both Stimulatory and Inhibitory Effects on Cell Surface and Soluble CD44 Binding to Hyaluronan , 1998, The Journal of cell biology.

[43]  B. Dörken,et al.  Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. , 1997, The Journal of clinical investigation.

[44]  K. Rajewsky,et al.  Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells , 1996, The Journal of experimental medicine.

[45]  H I Maibach,et al.  HYALURONIC ACID AND SKIN: WOUND HEALING AND AGING , 1996, International journal of dermatology.

[46]  J. Ortaldo,et al.  NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. , 1996, Journal of immunology.

[47]  Scott F. Smith,et al.  Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. , 1994, Science.

[48]  C. Mackay,et al.  Expression and modulation of CD44 variant isoforms in humans , 1994, The Journal of cell biology.

[49]  W. Greene,et al.  Cross‐coupling of the NF‐kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. , 1993, The EMBO journal.

[50]  S. Pileri,et al.  Lymphotoxin, tumour necrosis factor and interleukin‐6 gene transcripts are present in Hodgkin and Reed‐Sternberg cells of most Hodgkin's disease cases , 1993, British journal of haematology.

[51]  A. Gearing,et al.  Expression and cell distribution of the intercellular adhesion molecule, vascular cell adhesion molecule, endothelial leukocyte adhesion molecule, and endothelial cell adhesion molecule (CD31) in reactive human lymph nodes and in Hodgkin's disease. , 1992, The American journal of pathology.

[52]  A. Sappino,et al.  Tumor necrosis factor/cachectin and lymphotoxin gene expression in lymph nodes from lymphoma patients. , 1990, Blood.

[53]  S. Hsu,et al.  Production of tumor necrosis factor-alpha and lymphotoxin by cells of Hodgkin's neoplastic cell lines HDLM-1 and KM-H2. , 1989, The American journal of pathology.

[54]  Peter Angel,et al.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1 , 1988, Cell.

[55]  W. Fiers,et al.  Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. , 1987, Journal of immunology.

[56]  P. Prehm Hyaluronate is synthesized at plasma membranes. , 1984, The Biochemical journal.

[57]  Ralf Küppers,et al.  The biology of Hodgkin's lymphoma , 2009, Nature Reviews Cancer.

[58]  D. Adams,et al.  Expression and function of T cell homing molecules in Hodgkin’s lymphoma , 2008, Cancer Immunology, Immunotherapy.

[59]  C. Ware,et al.  The LT beta R signaling pathway. , 2007, Advances in experimental medicine and biology.

[60]  F. Luscinskas,et al.  Alpha4beta1-integrin activation is necessary for high-efficiency T-cell subset interactions with VCAM-1 under flow. , 2000, Microcirculation.

[61]  Y. Goltsev,et al.  Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.

[62]  M. Mohamadzadeh,et al.  Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. , 1998, The Journal of clinical investigation.

[63]  D. Jones,et al.  Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease. , 1990, The American journal of pathology.